Article
Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients
9 Nov 2024
Abstract excerpt
No abstract is available from the source.
Loading publication...
Back to search
Community interpretation
Discuss the evidence
Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.
0
discussions
0
replies
Citations encouraged
Claims remain attributable.
No discussion yet
Be the first to add a careful, cited interpretation.